達實智能(002421.SZ)中標深圳城市軌道交通13號線二期綜合監控系統採購項目
格隆匯7月13日丨達實智能(002421.SZ)公告,近日收到招標人港鐵中鐵電化軌道交通(深圳)有限公司及招標代理機構廣東粵能工程管理有限公司發出的《中標通知書》,中標由香港鐵路有限公司運營的深圳市城市軌道交通13號線二期綜合監控系統採購項目,中標金額爲1.22億元。
服務內容:公司將基於自主研發的AIoT智能物聯網管控平臺,聚合多種創新性應用,爲該項目提供涵蓋工控雲線路接入系統、大數據及智慧車站、綜合監控系統(含EMCS、PSCADA、能源管理)、MCC系統、車場智能化系統及相關服務的智慧交通整體解決方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.